The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
2021 · Nature · 436 citations
https://doi.org/10.1038/s41586-021-03341-5
B
Brian Hardaway
WinnMed(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
766
Citations
9
h-index
9
i10-index
Brian Hardaway is an academic researcher from WinnMed. The author has contributed to research in topics: Transplantation: Methods and Outcomes & Mechanical Circulatory Support Devices & Cardiac Structural Anomalies and Repair. The author has an h-index of 9, co-authored 44 publications.
ORCID: 0000-0003-0622-3494Papers by this author
worksAggressive Cholesterol Lowering Normalizes Atherosclerosis Regression in <i> Jak2 <sup>V617F</sup> </i> Mice
2025 · bioRxiv (Cold Spring Harbor Laboratory) · 1 citations
https://doi.org/10.1101/2025.07.23.666334
SAFETY AND EFFICACY OUTCOMES OF ENDOBARIATRIC THERAPIES (EBTS) AND LIFESTYLE INTERVENTION IN SOLID ORGAN TRANSPLANT PATIENTS: A SINGLE-CENTER PROSPECTIVE PILOT STUDY
2024 · Gastrointestinal Endoscopy · 0 citations
https://doi.org/10.1016/j.gie.2024.04.747
Unexpected increase in calculated panel reactive antibody & positive retrospective crossmatch in a heart transplant recipient induced by intra-aortic balloon pump
2025 · Human Immunology · 0 citations
https://doi.org/10.1016/j.humimm.2025.111390
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat